Treace Medical Concepts Is Maintained at Equal-Weight by Morgan Stanley

Treace Medical Concepts Is Maintained at Equal-Weight by Morgan

Dow Jones13:13 ET

Treace Medical Concepts Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 -1.23% Morgan Stanley $5.5 → $8 Maintains Equal-Weight 05/16/2024 -19.75% UBS $16 → $6.5

Benzinga13:02 ET

Express News | Treace Medical Concepts Inc : Morgan Stanley Raises Target Price to $8.00 From $5.50

ReutersJul 15 09:08 ET

Morgan Stanley Raises Price Target on Treace Medical Concepts to $8 From $5.50, Keeps Equalweight Rating

Treace Medical Concepts (TMCI) has an average investment rating of hold among analysts polled by Capital IQ, with price targets ranging from $6 to $8.

MT NewswiresJul 15 07:25 ET

Cautious Investors Not Rewarding Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Performance Completely

You may think that with a price-to-sales (or "P/S") ratio of 2.1x Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a stock worth checking out, seeing as almost half of all the Medical Equipment companie

Simply Wall StJul 1 09:56 ET

Treace Medical Concepts(TMCI.US) 10% Shareholder Buys US$264.6K in Common Stock

$Treace Medical Concepts(TMCI.US)$ 10% Shareholder Treace John T. purchased 45,000 shares of common stock on Jun 11, 2024 at an average price of $5.88 for a total value of $264.6K.Source: Announcement

moomoo NewsJun 11 18:11 ET